IGF1R and colorectal carcinoma: As a matter of fact, miR-143 targets IGF-1R resulting in oxaliplatin resistance [97] and, indeed, overexpression of miR-143 was reported to re-sensitize CRC cells to such therapeutic by caspases activation [97].